IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,774,388 | -34.8% | 1,049,934 | +7.3% | 0.00% | 0.0% |
| Q2 2023 | $2,720,361 | +108.9% | 978,547 | +36.7% | 0.00% | – |
| Q1 2023 | $1,302,456 | -64.5% | 715,635 | -1.1% | 0.00% | -100.0% |
| Q4 2022 | $3,668,241 | +3.6% | 723,519 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $3,540,000 | +100.6% | 712,218 | +50.2% | 0.00% | 0.0% |
| Q2 2022 | $1,765,000 | -36.2% | 474,270 | -3.8% | 0.00% | 0.0% |
| Q1 2022 | $2,767,000 | -4.5% | 493,059 | +3.5% | 0.00% | 0.0% |
| Q4 2021 | $2,897,000 | -35.1% | 476,387 | +4.0% | 0.00% | 0.0% |
| Q3 2021 | $4,463,000 | -36.5% | 458,205 | -6.8% | 0.00% | -50.0% |
| Q2 2021 | $7,024,000 | +15.0% | 491,859 | +91.2% | 0.00% | 0.0% |
| Q1 2021 | $6,107,000 | – | 257,228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |